Live Breaking News & Updates on Gip

Stay informed with the latest breaking news from Gip on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Gip and stay connected to the pulse of your community

BlackRock assets hit record $10.5 trillion as markets surge

BlackRock announced in January the acquisition of Global Infrastructure Partners (GIP) for $12.5 billion, as the asset manager aims to expand into private markets and alternative assets through infrastructure investments around the globe.

Bengaluru , Karnataka , India , Shinjini-ganguli , Larry-fink , Arasu-kannagi-basil , Paul-simao , Ira-iosebashvili , Blackrock , Global-infrastructure-partners , Blackrock-chief-financial-officer-martin-small , Shares-bitcoin-trust

How two different, expensive healthcare systems on this island have managed to (occasionally) work well together

An all-island milk bank, children’s heart care, and cancer treatments has brought benefits – but research is needed for further health collaborations.

Cambridge , Cambridgeshire , United-kingdom , Armagh , Northern-ireland , Craigavon , Dublin , Ireland , Enniskillen , Fermanagh , Belfast , Irish

Me-two drug? Viking mid-stage trial wins with GLP-1/GIP bid

The enticing prospect – and proven worth – of dually agonizing the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors gained more evidence in a big way from Viking Therapeutics Inc. with VK-2735 in a phase II weight loss study. Shares of San Diego-based Viking Therapeutics Inc. (NASDAQ:VKTX) closed Feb. 27 at $85.05, up $46.57, or 121%, as investors learned that the drug achieved the primary and all secondary endpoints in the phase II study called Venture, with significant body-weight drops at all doses compared to placebo.

Nasdaq , San-viking-therapeutics-inc , Therapeutics-inc , Viking-therapeutics , San-diego-based-viking-therapeutics , Viking-therapeutics-inc- , Vk-2735 , Glp-1 , Gip , Bioworld , Clinical

How SunPower Narrowly Avoided Bankruptcy With 'Trojan Horse' Rescue Deal

Expensive financing helps troubled solar company survive a few more months.

France , United-states , Blackrock , California , China , America , French , Peter-faricy , Sunpower-sunvault , Gordon-johnson , December-sunpower , Tom-werner

The art of moneymaking by Blackstone, BlackRock

Two major events are shaking up the asset management world.

Blackrock , United-kingdom-general- , United-kingdom , London , City-of , Sydney , New-south-wales , Australia , Shuli-ren , Blackrock-inc , Blackstone-inc , Dimensional-fund-advisors

BlackRock to buy GIP in US$12.5-billion deal; fourth-quarter profit rises on stronger AUM

BlackRock said it will buy GIP for $3-billion in cash and roughly 12 million Blackrock shares to create an investing platform with more than $150-billion in combined assets

Blackrock , Nova-scotia , Canada , Log-increate-free , Global-infrastructure-partners , Infrastructure , Gip , Deal , Asset , Share , Management

FL Legislature must expand state health insurance to Florida College System employees

Currently, the public servants of the Florida College System do not have access to the attractive State Group Insurance Program (SGIP).

State-of-florida , Florida , United-states , Indian-river , Florida-college , Floridians , Kathleen-passidomo , Timothye-moore , Dominicm-calabro , Paul-renner , Department-of-management-services , Florida-college-system-risk-management-consortium

'Dualing' obesity drugs: Roche's $2.7B buyout of Carmot driven by Mounjaro twin mechanism

The same mechanism of action deployed by Eli Lilly and Co.’s obesity drug Mounjaro (tirzepatide) helped lure Roche Holding AG to the buyout of Carmot Therapeutics Inc., as the pharma giant agreed to pay $2.7 billion up front for the privately held outfit, promising another $400 million if milestones are met.

Eli-lilly , Carmot-therapeutics-inc , Roche-holding , Carmot-therapeutics-inc- , Roche-holding-ag , Ct-388 , Glp-1 , Gip , Ct-996 , Type-2-diabetes , Ct-868 , Glucagon-like-peptide-1-receptor-antagonist

Green Impact Partners (CVE:GIP) Price Target Cut to C$4.00 by Analysts at Cormark

Green Impact Partners (CVE:GIP – Free Report) had its price target decreased by Cormark from C$6.00 to C$4.00 in a report released on Thursday, BayStreet.CA reports. Green Impact Partners Stock Down 7.8 % Shares of CVE:GIP opened at C$3.66 on Thursday. The firm has a fifty day moving average price of C$4.55 and a two-hundred […]

United-states , America , Green-impact-partners-company-profile , Green-impact-partners-inc , Energy-production , Green-impact-partners , Free-report , Impact-partners-stock-down , Impact-partners , Get-free-report , Impact-partners-inc

Diabetes, the silent killer behind billions in hidden costs

As the world commemorated World Diabetes day, SA should be doing more to focus on access to diagnosis and treatment to help our fiscus

South-africa , World-war , Sunday-times , Ncd , Sa , Health-promotion-levy , Bmi , Aspen , Wits-university , Priceless-sa , Sa-39s-second-biggest-killer